Cardiovascular Pharmacology: Heart and circulation, Vol 59. Advances in Pharmacology

  • ID: 1757949
  • Book
  • 344 Pages
  • Elsevier Science and Technology
1 of 4

Cardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions.

  • Contains up-to-date reviews of the most important emerging cardiovascular therapies written by world leaders in the field

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 4
- Ryanodine Receptors in Cardiac Physiology and Disease
Andrew Marks and Alexander Kushnir

- Neuregulin-1/ErbB Signaling and Chronic Heart Failure
Yabei Xu, Xinyan Li, Xifu Liu, and Mingdong Zhou

- If Inhibition in Cardiovascular Diseases
Catherine Thollon and Jean-Paul Vilaine

- Pharmacology of Cardiac Potassium Channels
Gui-Rong Li and Ming-Qing Dong

- Beta3-Adrenergic Receptors in Cardiac and Vascular Tissues: Emerging Concepts and Therapeutic Perspectives
Chantal Dessy and Jean-Luc Balligand

- Modulation of Vascular Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA) in Cardiovascular Pathophysiology
Takeshi Ken Adachi

- Advances in the Renin Angiotensin System: Focus on Angiotensin Converting Enzyme 2 and Angiotensin-(1-7) - Carlos M. Ferrario and Jewell Jessup

- The Role of Calpain in Diabetes-associated Platelet Hyperactivation
Voahanginirina Randriamboavonjy and Ingrid Fleming

- Tissue Factor and Cardiovascular Disease
Erik Holy and Felix C. Tanner
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Vanhoutte, Paul.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll